| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1031224661 |
| P356 | DOI | 10.1038/30400 |
| P698 | PubMed publication ID | 9607760 |
| P50 | author | Alan Storey | Q64101624 |
| Judith Breuer | Q37366620 | ||
| P2093 | author name string | Thomas M | |
| Banks L | |||
| Mantovani F | |||
| Matlashewski G | |||
| Leigh IM | |||
| Storey A | |||
| Gardiol D | |||
| Kalita A | |||
| Harwood C | |||
| P2860 | cites work | Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia | Q68224970 |
| Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation | Q70168032 | ||
| Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer | Q70459077 | ||
| Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6 | Q70995998 | ||
| P53 polymorphisms and haplotypes in lung cancer | Q71730111 | ||
| Is p53 polymorphism maintained by natural selection? | Q72720085 | ||
| Identification of a novel p53 functional domain that is necessary for efficient growth suppression | Q24311276 | ||
| Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules | Q28248180 | ||
| Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin | Q28300614 | ||
| Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy | Q28775735 | ||
| The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
| The ubiquitin system for protein degradation | Q29614385 | ||
| The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product | Q29618372 | ||
| Structural basis for the binding of proline-rich peptides to SH3 domains | Q29620408 | ||
| Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. | Q33929053 | ||
| p53 function and dysfunction | Q35721291 | ||
| Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution | Q35756977 | ||
| The mechanism and functions of ATP-dependent proteases in bacterial and animal cells | Q36736334 | ||
| The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines | Q37537138 | ||
| The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes | Q39101956 | ||
| Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients | Q40007123 | ||
| Primary structure polymorphism at amino acid residue 72 of human p53. | Q40658642 | ||
| The polyproline region of p53 is required to activate apoptosis but not growth arrest. | Q41093439 | ||
| Histopathology of skin lesions in renal allograft recipients--an assessment of viral features and dysplasia | Q42492863 | ||
| Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients | Q42517979 | ||
| Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies | Q42605420 | ||
| Association of human papillomavirus types 16 and 18 E6 proteins with p53. | Q43701619 | ||
| Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. | Q53461751 | ||
| Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. | Q53473378 | ||
| Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. | Q54422442 | ||
| Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. | Q55066453 | ||
| P433 | issue | 6682 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 229-234 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Role of a p53 polymorphism in the development of human papillomavirus-associated cancer | |
| P478 | volume | 393 |
| Q37522021 | "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences". |
| Q54740167 | A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. |
| Q44855820 | A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism |
| Q35749285 | A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer |
| Q78555008 | A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene |
| Q64053966 | A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin |
| Q43034453 | A p53 polymorphism associated with increased risk of hepatitis C virus infection |
| Q47818899 | A phylogenetic approach to assessing the significance of missense mutations in disease genes |
| Q43516656 | Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China |
| Q74418572 | Absence of germline and somatic p53 alterations in children with sporadic brain tumors |
| Q36618315 | Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis |
| Q43544690 | Alterations in exon 4 of the p53 gene in gastric carcinoma |
| Q53332341 | Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden. |
| Q34251029 | Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas |
| Q53150503 | Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. |
| Q81204537 | Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates |
| Q34570100 | Assessing TP53 status in human tumours to evaluate clinical outcome |
| Q30840039 | Association between TP53 gene Arg72Pro polymorphism and Wilms' tumor risk in a Chinese population |
| Q35065411 | Association between p53 codon 72 (Arg72Pro) polymorphism and primary open-angle glaucoma in Iranian patients. |
| Q44967236 | Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women |
| Q47134492 | Association of Cervical Cancer Screening with Knowledge of Risk Factors, Access to Health Related Information, Health Profiles, and Health Competence Beliefs among Community-Dwelling Women in Japan |
| Q44991537 | Association of DCC, MLH1, GSTT1, GSTM1, and TP53 gene polymorphisms with colorectal cancer in Kazakhstan |
| Q33600639 | Association of Human Papilloma Virus 16 Infection and p53 Polymorphism among Tobacco using Oral Leukoplakia Patients: A Clinicopathologic and Genotypic Study |
| Q42221337 | Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk |
| Q37615307 | Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan |
| Q77359729 | Association of codon 72 polymorphism of p53 with lower prostate cancer risk |
| Q34241885 | Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer |
| Q36925192 | Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation |
| Q92042386 | Association of miR-34b/c rs4938723 and TP53 Arg72Pro Polymorphisms with Neuroblastoma Susceptibility: Evidence from Seven Centers |
| Q46468190 | Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population |
| Q44786549 | Association of p53 arginine polymorphism with skin cancer |
| Q55297633 | Association of p53 codon 72 Arg>Pro polymorphism and risk of cancer in Iranian population: A systematic review and meta-analysis. |
| Q84613015 | Association of p53 codon 72 genetic polymorphism with the risk of ulcerative colitis in northern Iran |
| Q36624424 | Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes |
| Q38184472 | Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis |
| Q46943513 | Association of p53 codon 72 polymorphism with risk of hypopharyngeal squamous cell carcinoma in Taiwan |
| Q35588284 | Association of specific genotype and haplotype of p53 gene with cervical cancer in India |
| Q36571067 | Bonafide, type-specific human papillomavirus persistence among HIV-positive pregnant women: predictive value for cytological abnormalities, a longitudinal cohort study |
| Q98163452 | Both p53 codon 72 Arg/Arg and pro/Arg genotypes in glioblastoma multiforme are associated with a better prognosis in bevacizumab treatment |
| Q33877018 | Cervical cancer risk: is there a genetic component? |
| Q36777343 | Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson |
| Q33693838 | Clinical outcomes and correlates of TP53 mutations and cancer |
| Q86657629 | Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients |
| Q44119126 | Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix. |
| Q78044334 | Codon 72 polymorphism of p53 and its association with cervical cancer |
| Q37699997 | Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population |
| Q43202487 | Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity |
| Q73798162 | Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma |
| Q52899617 | Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. |
| Q28386766 | Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore |
| Q36959022 | Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers |
| Q28397067 | Combined p53-related genetic variants together with HPV infection increase oral cancer risk |
| Q92455292 | Common genetic variants in the TP53 pathway and their impact on cancer |
| Q37392961 | Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited |
| Q40052836 | Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. |
| Q24541311 | Comparative analysis of cancer genes in the human and chimpanzee genomes |
| Q35805818 | Complex SNP-based haplotypes in three human helicases: implications for cancer association studies |
| Q33886737 | Contemporary theories of cervical carcinogenesis: the virus, the host, and the stem cell |
| Q36383234 | Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer |
| Q42501349 | Cutaneous squamous cell carcinoma and p53 codon 72 polymorphism: a need for screening? |
| Q24170411 | DNA sequence variants of p53: cancer and aging (letters to the editor) |
| Q33588367 | Demystified ... p53. |
| Q41742178 | Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients. |
| Q24811531 | Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina |
| Q33969680 | Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis |
| Q44357056 | Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas |
| Q28360872 | Determination of p53 genotypes in oral cancer patients from India |
| Q53404639 | Development of spontaneous hyperplastic skin lesions and chemically induced skin papillomas in transgenic mice expressing human papillomavirus type 16 E6/E7 genes. |
| Q34082219 | Disrupted human-pathogen co-evolution: a model for disease |
| Q35589844 | Distributions of p53 codon 72 polymorphism in primary open angle glaucoma |
| Q33788778 | Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses |
| Q37617512 | Does p53 codon 72 polymorphism have a prognostic value in carcinoma of the vulva and vagina? |
| Q48280009 | Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) Complexes. |
| Q40790307 | Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. |
| Q28291338 | E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box |
| Q40896659 | E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage |
| Q44750566 | Ebselen-mediated protection from single and repeated noise exposure in rat. |
| Q58736915 | Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis |
| Q54683733 | Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium. |
| Q37658637 | Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India |
| Q44955068 | Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma |
| Q40615186 | Efficient growth inhibition of HPV 16 E6-expressing cells by an adenovirus-expressing p53 homologue p73beta. |
| Q35162361 | Environmental exposure and lung cancer among nonsmokers: an example of Taiwanese female lung cancer |
| Q45089606 | Epidemiology and natural history of genital infection by human papillomavirus |
| Q90736751 | Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation |
| Q24802483 | Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer |
| Q35071587 | Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells |
| Q34025309 | Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene |
| Q34012715 | Evaluation of p53 codon 72 polymorphism in adenocarcinomas of the colon and rectum in La Plata, Argentina |
| Q59358239 | Exploring the Causes of the Low Incidence of Cervical Cancer in Western Asia |
| Q36916029 | Exploring the relation between human papilloma virus and larynx cancer. |
| Q40171518 | Expression of Human Papillomavirus DNA and p53 Polymorphisms through Polymerase Chain Reaction in Normal Mucosa and Oral Leukoplakia Individuals with Deleterious Oral Habits |
| Q37037859 | Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma |
| Q77807971 | Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan |
| Q77526150 | Familial cancer history in patients with carcinoma of the cervix uteri |
| Q74234596 | Familial cancer risks in affected sibships: results from the Swedish family-cancer database |
| Q33732313 | Familial cervical cancer: case reports, review and clinical implications. |
| Q43039314 | Functional analysis of the p53 codon 72 polymorphism in black South Africans with rheumatoid arthritis--a pilot study |
| Q36007941 | Functional characterization of the A411T (L137F) and G364A (D122N) genetic polymorphisms in human N-acetyltransferase 2. |
| Q38451813 | G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value |
| Q36982644 | Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers |
| Q36475800 | Gene-gene, gene-environment & multiple interactions in colorectal cancer |
| Q35025532 | Genetic Polymorphism of Cancer Susceptibility Genes and HPV Infection in Cervical Carcinogenesis |
| Q34355987 | Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. |
| Q36831101 | Genetic factors associated with skin cancer in renal transplant patients |
| Q35110921 | Genetic influence on cigarette-induced cardiovascular disease |
| Q31889996 | Genetic mechanisms in squamous cell carcinoma of the head and neck |
| Q53352506 | Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. |
| Q44816536 | Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women |
| Q36683202 | Genetic susceptibility of cervical cancer |
| Q33716371 | Genetic susceptibility to HPV infection and cervical cancer |
| Q38560697 | Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes |
| Q33764029 | Genetic susceptibility to non-polyposis colorectal cancer |
| Q41017874 | Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma |
| Q48345170 | Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma |
| Q36911839 | Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer |
| Q37344931 | Germline polymorphism of cancer susceptibility genes in gynecologic cancer |
| Q54642739 | Germline polymorphism of p53 codon 72 in gynecological cancer. |
| Q42776490 | Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis |
| Q44898564 | Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells |
| Q45274582 | Glutathione-S-transferase and p53 polymorphisms in cervical carcinogenesis |
| Q43904966 | HIV/HPV co-infection during pregnancy in southeastern Brazil: prevalence, HPV types, cytological abnormalities and risk factors. |
| Q89834860 | HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy? |
| Q77657982 | HPV and cancer: the story unfolds |
| Q36858694 | HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia |
| Q24235871 | HPV testing versus cervical cytology for screening for cancer of the uterine cervix |
| Q24239827 | HPV testing versus cervical cytology for screening for cancer of the uterine cervix |
| Q40308181 | HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. |
| Q34144298 | Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium |
| Q57697518 | Heritability of cervical tumours |
| Q42262374 | Heterozygote of PLCE1 rs2274223 increases susceptibility to human papillomavirus infection in patients with esophageal carcinoma among the Kazakh populations |
| Q33743767 | High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma |
| Q34382727 | Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population |
| Q53428355 | Homozygous arginine-72 in wild type p53 and risk of cervical cancer. |
| Q36043405 | How frequent is altered gene expression among susceptibility genes to human complex disorders? |
| Q48022719 | How to decide whether small samples comply with an equidistribution |
| Q38635643 | Human Genetic Determinants of Viral Diseases |
| Q42804946 | Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein |
| Q51949769 | Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. |
| Q33727125 | Human papillomavirus and the development of non-melanoma skin cancer |
| Q33746083 | Human papillomavirus and urological tumours: I. Basic science and role in penile cancer |
| Q33948260 | Human papillomavirus in cervical neoplasia. Role, risk factors, and implications. |
| Q40760209 | Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. |
| Q34204141 | Human papillomavirus infections: epidemiology, pathogenesis, and therapy |
| Q34796393 | Human papillomavirus molecular biology and pathogenesis |
| Q91924636 | Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly |
| Q42179078 | Human papillomavirus types detected in skin warts and cancer differ in their transforming properties but commonly counteract UVB induced protective responses in human keratinocytes |
| Q44235224 | Human papillomavirus-associated diseases in Israel--the controversy continues. Foreword |
| Q34743451 | Human papillomavirus: a review |
| Q36550902 | Human papillomaviruses and cervical cancer |
| Q40718202 | IGFBP-3 mediates p53-induced apoptosis during serum starvation. |
| Q34347454 | Identification of a G(2) arrest domain in the E1 wedge E4 protein of human papillomavirus type 16. |
| Q30939321 | Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy |
| Q36619769 | Identification of tumour-associated and germ line p53 mutations in canine mammary cancer |
| Q35050810 | Immune profiling and cancer post transplantation |
| Q59390039 | Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix |
| Q33814477 | Immunohistochemical analysis, human papillomavirus DNA detection, hormonal manipulation, and exogenous gene expression of normal and dysplastic human cervical epithelium in severe combined immunodeficiency mice. |
| Q33541956 | Immunotherapeutic strategies for cervical squamous carcinoma |
| Q62631293 | Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population |
| Q36449988 | Implication of DNA repair genes in prostate tumourigenesis in Indian males. |
| Q24813088 | In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis |
| Q73235255 | Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment |
| Q77854249 | Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines |
| Q60918337 | Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study |
| Q85597772 | Interactions between E6AP and E6 proteins from alpha and beta HPV types |
| Q35984539 | Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population |
| Q37983630 | Is cellular senescence an example of antagonistic pleiotropy? |
| Q37362882 | Lack of correlation between p53 codon 72 polymorphism and anal cancer risk |
| Q37626495 | Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer |
| Q46626572 | Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women |
| Q41810748 | Low risk HPV-E6 traps p53 in the cytoplasm and induces p53-dependent apoptosis |
| Q54198614 | Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population. |
| Q35945077 | MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors |
| Q35572466 | Mdm2: A regulator of cell growth and death |
| Q28191320 | Measurement of Brn-3a levels in Pap smears provides a novel diagnostic marker for the detection of cervical neoplasia |
| Q74141703 | Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene |
| Q33669236 | Microplate array diagonal gel electrophoresis for mutation research in DNA banks |
| Q40982606 | Mitogen-activated protein kinase is involved in the degradation of p53 protein in the bryostatin-1-induced differentiation of the acute promyelocytic leukemia NB4 cell line |
| Q37589252 | Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility |
| Q36306666 | Molecular basis for advances in cervical screening |
| Q72993916 | Molecular evolution of the thermosensitive PAb1620 epitope of human p53 by DNA shuffling |
| Q35560090 | Molecular markers in cervical cytology |
| Q38464809 | Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers |
| Q35645033 | Multicenter initiative seeking critical genes in respiratory papillomatosis |
| Q40941698 | Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours |
| Q33957704 | New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen |
| Q49216581 | No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects |
| Q35592238 | No association of p53 codon 72 and p21 codon 31 polymorphisms in Taiwan Chinese patients with pterygium |
| Q39199067 | No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients |
| Q53553113 | No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency. |
| Q38412273 | No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer |
| Q36832230 | Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer. |
| Q64269842 | Nucleotide variants and protein expression of TP53 in a Sri Lankan cohort of patients with head and neck cancer |
| Q33292379 | Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation |
| Q55712493 | Optimal regimen of cisplatin in squamous cell carcinoma of head and neck yet to be determined. |
| Q30940434 | P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. |
| Q90290646 | P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study |
| Q34194142 | P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions |
| Q34885831 | P53 codon 11, 72, and 248 gene polymorphisms in endometriosis |
| Q44013374 | P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype |
| Q74300539 | P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study |
| Q44282464 | P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women |
| Q74689136 | P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency |
| Q35678099 | P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility |
| Q34654068 | P53 gene codon 72 polymorphism in patients with oral squamous cell carcinoma in the population of northern Iran. |
| Q37475856 | P53 genetic polymorphism of gastric cancer in Korea |
| Q77995520 | Papillomavirus and p53 codon 72 polymorphism |
| Q48024480 | Papillomavirus and p53. |
| Q43970136 | Parkinsonism proteolysis and proteasomes |
| Q34571747 | Persistent human papillomavirus infection and cervical neoplasia |
| Q47827853 | Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology. |
| Q36430172 | Polymorphic variants in the p53 pathway. |
| Q30305598 | Polymorphism at codon 72 of p53 is not associated with cervical cancer risk |
| Q44878665 | Polymorphism at codon 72 of the p53 gene is not associated with endometriosis in a Japanese population |
| Q59849500 | Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer |
| Q53660060 | Polymorphism of codon 72 of p53 and environmental factors in the development of cervical cancer. |
| Q37658624 | Polymorphism of p53 in cancer prognosis |
| Q44631153 | Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. |
| Q35774090 | Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis |
| Q43977629 | Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa |
| Q47689233 | Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis |
| Q51840083 | Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. |
| Q37293815 | Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatment |
| Q36426763 | Polymorphisms in the p53 pathway. |
| Q45031032 | Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. |
| Q35578056 | Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls |
| Q38436369 | Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis |
| Q73539228 | Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia |
| Q40550047 | Prediction of survival in surgical unresectable lung cancer by artificial neural networks including genetic polymorphisms and clinical parameters |
| Q43864446 | Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India |
| Q38137191 | Prevalence of human papillomavirus in epithelial ovarian cancer tissue. A meta-analysis of observational studies. |
| Q36255905 | Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study. |
| Q53318912 | Prognostic factors and biomarkers of penile carcinoma. |
| Q27863379 | Prognostic role of p53 codon 72 polymorphism in gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy. |
| Q44198329 | Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women |
| Q92446071 | Protein Oxidative Damage in UV-Related Skin Cancer and Dysplastic Lesions Contributes to Neoplastic Promotion and Progression |
| Q44958191 | Psychosocial factors and the course of cervical intra-epithelial neoplasia: a prospective study |
| Q52959151 | Psychosocial factors and the grade of cervical intra-epithelial neoplasia: a semi-prospective study. |
| Q33835617 | Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence |
| Q46593008 | Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury |
| Q46903118 | Reply to niermeijer |
| Q37014519 | Response to microtubule-interacting agents in primary epithelial ovarian cancer cells |
| Q36640866 | Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. |
| Q36352077 | Risk of second cancers after radiotherapy for cervical cancer |
| Q40445624 | Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins |
| Q74176507 | Role of a p53 polymorphism in luminal narrowing after balloon coronary angioplasty |
| Q41358569 | Role of a p53 polymorphism in the development of nonfunctional pituitary adenomas |
| Q33997001 | Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients |
| Q36681902 | Role of human papillomavirus and cell cycle-related variants in squamous cell carcinoma of the oropharynx |
| Q37370785 | Role of p53 codon 72 polymorphism in chromosomal aberrations and mitotic index in patients with chronic hepatitis B. |
| Q46446736 | Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer |
| Q34928345 | Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer |
| Q34226397 | Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells |
| Q35960434 | Significant association between functional microRNA polymorphisms and head and neck cancer susceptibility: a comprehensive meta-analysis |
| Q54431007 | Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia. |
| Q36889725 | Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program |
| Q38210273 | Skin cancer in kidney transplant recipients. |
| Q37295608 | Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression |
| Q36032937 | Smoking-gene interaction and disease development: relevance to pancreatic cancer and atherosclerosis |
| Q36187364 | Somatic Variations in Cervical Cancers in Indian Patients |
| Q43594625 | Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors |
| Q43233483 | Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits |
| Q34240418 | Surrogate endpoint biomarkers and their modulation in cervical chemoprevention trials |
| Q38602946 | Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas |
| Q34717543 | TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis |
| Q55060818 | TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer. |
| Q46597593 | TP53 Gene Polymorphisms and Occupational Skin Cancer Risks for Workers of Glass Fiber Manufacture |
| Q34601749 | TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India |
| Q47094502 | TP53 R72P Polymorphism and Susceptibility to Human Papillomavirus Infection Among Women With Human Immunodeficiency Virus in Morocco: A Case-control Study |
| Q36085572 | TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development. |
| Q36735447 | TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses |
| Q35799814 | TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells |
| Q33485646 | TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. |
| Q45897985 | TP53 codon 72 polymorphism and risk of cervical carcinoma in Serbian women |
| Q43632535 | TP53 codon 72 polymorphism in 12 populations of insular Southeast Asia and Oceania |
| Q50251932 | TP53 codon 72 polymorphism in pigmentary phenotypes |
| Q37565322 | TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma. |
| Q54423455 | TP53 genetic polymorphisms and environmental risk factors associated with cervical carcinogenesis in a cohort of Brazilian women with cervical lesions. |
| Q75322513 | TP53 haplotype-based analysis and incidence of post-angioplasty restenosis |
| Q36777326 | TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes |
| Q33685392 | TP53 mutations in human cancers: origins, consequences, and clinical use |
| Q44011664 | TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions |
| Q55463635 | TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. |
| Q33723403 | TP53, MDM2, NQO1, and susceptibility to cervical cancer |
| Q34568607 | TP53: a key gene in human cancer. |
| Q46676306 | Teaching about genetic testing issues in the undergraduate classroom: a case study |
| Q45747090 | The Brn-3a transcription factor plays a critical role in regulating human papilloma virus gene expression and determining the growth characteristics of cervical cancer cells |
| Q74421281 | The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo |
| Q28484331 | The Pro allele of the p53 codon 72 polymorphism is associated with decreased intratumoral expression of BAX and p21, and increased breast cancer risk |
| Q36616536 | The R72P P53 mutation is associated with familial breast cancer in Jewish women |
| Q41824357 | The Somatic Nature of Cancer Allows It to Affect Highly Constrained Genes |
| Q35612785 | The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients |
| Q52308426 | The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis. |
| Q24673148 | The causal relation between human papillomavirus and cervical cancer |
| Q40672888 | The codon 72 polymorphic variants of p53 have markedly different apoptotic potential |
| Q40203781 | The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models |
| Q36810210 | The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan |
| Q44886980 | The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. |
| Q53418568 | The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. |
| Q33593937 | The emerging p53 gene family |
| Q37681979 | The enzymes in ubiquitin-like post-translational modifications |
| Q48627035 | The ethical implications of genetic testing in the classroom |
| Q34468780 | The human papillomavirus E6 protein and its contribution to malignant progression |
| Q34635024 | The oncogenic potential of human papillomaviruses: a review on the role of host genetics and environmental cofactors |
| Q73739882 | The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma |
| Q46266489 | The p53 codon 72 polymorphism in black South African women and the risk of cervical cancer |
| Q35078417 | The p53 network in head and neck cancer |
| Q34935933 | The p53 network in lung carcinogenesis. |
| Q41602036 | The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women. |
| Q37065135 | The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients |
| Q54786227 | The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up. |
| Q43846887 | The proline form of p53 codon 72 polymorphism is associated with endometriosis |
| Q37402233 | The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. |
| Q84066531 | The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer |
| Q35078768 | The role of TP53 in Cervical carcinogenesis. |
| Q37779889 | The role of genetic variants in human longevity |
| Q73314718 | The role of p53 in megakaryocyte differentiation and the megakaryocytic leukemias of Down syndrome |
| Q35142669 | The role of p53 in the immunobiology of cutaneous squamous cell carcinoma |
| Q33807833 | The role of the E6-p53 interaction in the molecular pathogenesis of HPV. |
| Q36643598 | The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas |
| Q29619270 | The ubiquitin-proteasome pathway: on protein death and cell life |
| Q89469457 | Tongue carcinoma in young adults: a review of the literature |
| Q42446909 | Transition of cervical carcinoma in situ to invasive cancer: role of p16 INK4a expression in progression and in recurrence |
| Q40319779 | Trp53-dependent DNA-repair is affected by the codon 72 polymorphism |
| Q74107206 | Tumor hypoxia, p53, and prognosis in cervical cancers |
| Q73703327 | Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain |
| Q33807787 | Twenty years of p53 research: structural and functional aspects of the p53 protein |
| Q33868530 | Two polymorphic variants of wild-type p53 differ biochemically and biologically |
| Q36168638 | UV-induced skin cancer: similarities--variations |
| Q64258970 | Ubiquinol-cytochrome C reductase core protein II promotes tumorigenesis by facilitating p53 degradation |
| Q33358972 | Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk |
| Q33588095 | Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies |
| Q33846198 | Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease |
| Q34394771 | Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses |
| Q37854816 | Viral oncogenesis and its role in nonmelanoma skin cancer |
| Q30753189 | What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians |
| Q47155290 | p53 Codon 72 Gene Polymorphism Studies and p53 Expression by Immunohistochemistry in Oral Lesions as Risk Factor for Malignancy |
| Q43743141 | p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours |
| Q49963853 | p53 and miR-34b/c genetic variation and their impact on ulcerative colitis susceptibility |
| Q64452947 | p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low- and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix |
| Q50708734 | p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants. |
| Q44234398 | p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes |
| Q44299674 | p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China |
| Q40707172 | p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis |
| Q28367920 | p53 codon 72 polymorphism and human papillomavirus associated skin cancer |
| Q43913279 | p53 codon 72 polymorphism and its association with bladder cancer |
| Q38470977 | p53 codon 72 polymorphism and risk of cervical cancer in UK. |
| Q38984916 | p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. |
| Q45057824 | p53 codon 72 polymorphism and susceptibility malignancy of colorectal cancer in Taiwan |
| Q36642834 | p53 codon 72 polymorphism as a progression index for bladder cancer |
| Q30157908 | p53 codon 72 polymorphism in patients affected with ulcerative colitis |
| Q53286606 | p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study. |
| Q58813364 | p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx |
| Q45907530 | p53 codon 72 proline/arginine polymorphism and autoimmune thyroid diseases. |
| Q36386111 | p53 gene mutations are not required for early dissemination of cancer cells |
| Q35793421 | p53 mutations and expression in breast carcinoma in situ |
| Q55335882 | p53 mutations in classic and pleomorphic invasive lobular carcinoma of the breast. |
| Q64242299 | p53 polymorphism and association of human papillomavirus in oral submucous fibrosis and oral squamous cell carcinoma: A case-control study |
| Q61051651 | p53 polymorphism and cervical cancer |
| Q77647682 | p53 polymorphism and risk of cervical cancer |
| Q44080510 | p53 polymorphism and risk of cervical cancer |
| Q59072735 | p53 polymorphism and risk of cervical cancer |
| Q59072739 | p53 polymorphism and risk of cervical cancer |
| Q37376012 | p53 polymorphisms: cancer implications |
| Q37023158 | p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers |
| Q40464378 | p73 beta-expressing recombinant adenovirus: a potential anticancer agent. |
| Q44633578 | p73 can suppress the proliferation of cells that express mutant p53. |
| Q95728240 | ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women |
Search more.